1. Executive Summary |
2. Global Compounding Chemotherapy Market Introduction |
2.1. Global Compounding Chemotherapy Market – Taxonomy |
2.2. Global Compounding Chemotherapy Market –Definitions |
2.2.1. By Dose Type |
2.2.2. By Compounding Type |
2.2.3. By Delivery Method |
2.2.4. By Sterility |
2.2.5. By Technology |
2.2.6. By Region |
3. Global Compounding Chemotherapy Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Compounding Chemotherapy Market Dynamic Factors - Impact Analysis |
3.6. Global Compounding Chemotherapy Market – Competition Landscape |
4. Global Compounding Chemotherapy Market Analysis, 2017-2021 and Forecast, 2022-2028 |
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Compounding Chemotherapy Market, By Dose Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1. Chemotherapeutic |
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Non-Chemotherapeutics |
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Compounding Chemotherapy Market, By Compounding Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1. Pharmaceutical Ingredient Alteration (PIA) |
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM) |
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Pharmaceutical Dosage Alteration (PDA) |
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Compounding Chemotherapy Market, By Delivery Method, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1. Gravimetric Automated Compounding Device (weight-based) |
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Volumetric Automated Compounding Device (volume-based) |
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8. Global Compounding Chemotherapy Market Forecast, By Sterility, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1. Sterile |
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Non-sterile |
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9. Global Compounding Chemotherapy Market Forecast, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1. With Robotic Arms |
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Without Robotic Arms |
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
10. Global Compounding Chemotherapy Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.1. North America |
10.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.1.3. Market Opportunity Analysis |
10.2. Europe |
10.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.2.3. Market Opportunity Analysis |
10.3. Asia-Pacific |
10.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.3.3. Market Opportunity Analysis |
10.4. Latin America |
10.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.4.3. Market Opportunity Analysis |
10.5. Middle East and Africa |
10.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.5.3. Market Opportunity Analysis |
10.6. Global Compounding Chemotherapy Market - Opportunity Analysis Index, By Dose Type, By Compounding Type, By Delivery Method, By Sterility, By Technology, and Region, 2022-2028 |
11. North America Compounding Chemotherapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
11.1. Dose Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Chemotherapeutic |
11.1.2. Non-Chemotherapeutics |
11.1.3. Others |
11.2. Compounding Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Pharmaceutical Ingredient Alteration (PIA) |
11.2.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM) |
11.2.3. Pharmaceutical Dosage Alteration (PDA) |
11.3. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Gravimetric Automated Compounding Device (weight-based) |
11.3.2. Volumetric Automated Compounding Device (volume-based) |
11.4. Sterility Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Sterile |
11.4.2. Non-sterile |
11.5. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.5.1. With Robotic Arms |
11.5.2. Without Robotic Arms |
11.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.6.1. USA |
11.6.2. Canada |
11.7. North America Compounding Chemotherapy Market - Opportunity Analysis Index, By Dose Type, By Compounding Type, By Delivery Method, By Sterility, By Technology, and Country, 2022-2028 |
11.8. North America Compounding Chemotherapy Market Dynamics – Trends |
12. Europe Compounding Chemotherapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
12.1. Dose Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Chemotherapeutic |
12.1.2. Non-Chemotherapeutics |
12.1.3. Others |
12.2. Compounding Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Pharmaceutical Ingredient Alteration (PIA) |
12.2.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM) |
12.2.3. Pharmaceutical Dosage Alteration (PDA) |
12.3. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Gravimetric Automated Compounding Device (weight-based) |
12.3.2. Volumetric Automated Compounding Device (volume-based) |
12.4. Sterility Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Sterile |
12.4.2. Non-sterile |
12.5. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.5.1. With Robotic Arms |
12.5.2. Without Robotic Arms |
12.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.6.1. Germany |
12.6.2. UK |
12.6.3. France |
12.6.4. Spain |
12.6.5. Italy |
12.6.6. Russia |
12.6.7. Rest of Europe |
12.7. Europe Compounding Chemotherapy Market - Opportunity Analysis Index, By Dose Type, By Compounding Type, By Delivery Method, By Sterility, By Technology, and Country, 2022-2028 |
12.8. Europe Compounding Chemotherapy Market Dynamics – Trends |
13. Asia-Pacific Compounding Chemotherapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
13.1. Dose Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Chemotherapeutic |
13.1.2. Non-Chemotherapeutics |
13.1.3. Others |
13.2. Compounding Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Pharmaceutical Ingredient Alteration (PIA) |
13.2.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM) |
13.2.3. Pharmaceutical Dosage Alteration (PDA) |
13.3. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Gravimetric Automated Compounding Device (weight-based) |
13.3.2. Volumetric Automated Compounding Device (volume-based) |
13.4. Sterility Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Sterile |
13.4.2. Non-sterile |
13.5. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.5.1. With Robotic Arms |
13.5.2. Without Robotic Arms |
13.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.6.1. China |
13.6.2. India |
13.6.3. Japan |
13.6.4. ASEAN |
13.6.5. Australia & New Zealand |
13.6.6. Rest of Asia-Pacific |
13.7. Asia-Pacific Compounding Chemotherapy Market - Opportunity Analysis Index, By Dose Type, By Compounding Type, By Delivery Method, By Sterility, By Technology, and Country, 2022-2028 |
13.8. Asia-Pacific Compounding Chemotherapy Market Dynamics – Trends |
14. Latin America Compounding Chemotherapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
14.1. Dose Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Chemotherapeutic |
14.1.2. Non-Chemotherapeutics |
14.1.3. Others |
14.2. Compounding Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. Pharmaceutical Ingredient Alteration (PIA) |
14.2.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM) |
14.2.3. Pharmaceutical Dosage Alteration (PDA) |
14.3. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Gravimetric Automated Compounding Device (weight-based) |
14.3.2. Volumetric Automated Compounding Device (volume-based) |
14.4. Sterility Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Sterile |
14.4.2. Non-sterile |
14.5. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.5.1. With Robotic Arms |
14.5.2. Without Robotic Arms |
14.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.6.1. Brazil |
14.6.2. Mexico |
14.6.3. Rest of Latin America |
14.7. Latin America Compounding Chemotherapy Market - Opportunity Analysis Index, By Dose Type, By Compounding Type, By Delivery Method, By Sterility, By Technology, and Country, 2022-2028 |
14.8. Latin America Compounding Chemotherapy Market Dynamics – Trends |
15. Middle East and Africa Compounding Chemotherapy Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
15.1. Dose Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
15.1.1. Chemotherapeutic |
15.1.2. Non-Chemotherapeutics |
15.1.3. Others |
15.2. Compounding Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
15.2.1. Pharmaceutical Ingredient Alteration (PIA) |
15.2.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM) |
15.2.3. Pharmaceutical Dosage Alteration (PDA) |
15.3. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.3.1. Gravimetric Automated Compounding Device (weight-based) |
15.3.2. Volumetric Automated Compounding Device (volume-based) |
15.4. Sterility Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.4.1. Sterile |
15.4.2. Non-sterile |
15.5. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.5.1. With Robotic Arms |
15.5.2. Without Robotic Arms |
15.6. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
15.6.1. Gulf Cooperation Council (GCC) Countries |
15.6.2. South Africa |
15.6.3. Rest of MEA |
15.7. MEA Compounding Chemotherapy Market - Opportunity Analysis Index By Dose Type, By Compounding Type, By Delivery Method, By Sterility, By Technology, and Country, 2022-2028 |
15.8. MEA Compounding Chemotherapy Market Dynamics – Trends |
16. Competition Landscape |
16.1. Strategic Dashboard of Top Market Players |
16.2. Company Profiles (Introduction, Financial Analysis, Key Dose Types, Key Developments, Strategies, and SWOT Analysis) |
16.2.1. Pharma B.V. |
16.2.2. Arxium, Inc. |
16.2.3. Baxter International Inc. |
16.2.4. B. Braun Melsungen AG |
16.2.5. Comecer S.P.A. |
16.2.6. Dedalus S.P.A. |
16.2.7. Equashield, LLC. |
16.2.8. Grifols |
16.2.9. Icon Group |
16.2.10. Loccioni Group. |
16.2.11. Miller Pharmacy Inc. |
16.2.12. Omnicell, Inc. |
16.2.13. Pfizer, Inc. |
17. Research Methodology |
18. Key Assumptions and Acronyms |
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.